Tomoyuki Koga Selected Research

Proteins (Proteins, Gene)

1/2021	Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.
1/2017	Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.
3/2003	Structural regulation of a peptide-conjugated graft copolymer: a simple model for amyloid formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoyuki Koga Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 06/2010
15	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2012
8	Hemorrhage 08/2023 - 12/2008
4	Glioma (Gliomas) 04/2024 - 01/2019
4	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2021
1	Lymphoma (Lymphomas) 01/2023
1	Astrocytoma (Pilocytic Astrocytoma) 01/2023
1	Carcinogenesis 12/2022
1	Delirium 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2020
1	Meningioma (Meningiomas) 01/2018
1	Dehydration (Water Stress) 08/2017
1	Paresis (Hemiparesis) 02/2012
1	Paresthesia (Dysesthesia) 02/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2009
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 03/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2003
1	Atrophy 02/2003
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2002

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 07/2020 - 01/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2014
3	epidermal growth factor receptor VIIIIBA 04/2024 - 01/2017
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2003
3	Tyrosine (L-Tyrosine)FDA Link 12/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
2	EnzymesIBA 04/2024 - 01/2019
2	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2021
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 04/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2024
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	ChromatinIBA 01/2023
1	NFI Transcription FactorsIBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	MethyltransferasesIBA 01/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2022
1	GA-Binding Protein Transcription FactorIBA 12/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 11/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2021
1	TIC10 compoundIBA 01/2021
1	Haloperidol (Haldol)FDA LinkGeneric 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-11 (Interleukin 11)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	NAD (NADH)IBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2018
1	PolymersIBA 08/2017
1	MicellesIBA 08/2017
1	CytokinesIBA 01/2017
1	SurvivinIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	SRS-AIBA 05/2016
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2012
1	Peptides (Polypeptides)IBA 03/2003
1	Retinaldehyde (Retinal)IBA 02/2003
1	Cathepsin DIBA 02/2003
1	Dendrimers (Dendrons)IBA 05/2002
1	Glutamic Acid (Glutamate)FDA Link 05/2002

Therapy/Procedure

7	Aftercare (After-Treatment) 08/2023 - 12/2008
6	Therapeutics 02/2024 - 01/2014
4	Drug Therapy (Chemotherapy) 10/2019 - 01/2012
3	Radiotherapy 01/2023 - 06/2010
1	Heterologous Transplantation (Xenotransplantation) 02/2024
1	Palliative Care (Palliative Therapy) 01/2021
1	Brachytherapy 10/2019
1	Oral Administration 02/2012
1	Adjuvant Radiotherapy 06/2010
1	Particle Accelerators 08/2009
1	Catheters 03/2009